The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors-Reference-Cited by-同舟云学术

The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors

Published:2017-05-09 Issue:1 Volume:4 Page:201-208
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Challa Divya N. V.,Crowson Cynthia S.,Davis John M.

Funder

National Center for Advancing Translational Sciences

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s40744-017-0063-5.pdf

Reference21 articles.

1. Khan NA, Spencer HJ, Abda EA, et al. Patient’s global assessment of disease activity and patient’s assessment of general health for rheumatoid arthritis activity assessment: are they equivalent? Ann Rheum Dis. 2012;71(12):1942–9.

2. Markenson JA, Koenig AS, Feng JY, et al. Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort. J Clin Rheumatol. 2013;19(6):317–23.

3. Smedstad LM, Kvien TK, Moum T, Vaglum P. Correlates of patients’ global assessment of arthritis impact. A 2-year study of 216 patients with RA. Scand J Rheumatol. 1997;26(4):259–65.

4. Studenic P, Radner H, Smolen JS, Aletaha D. Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. Arthritis Rheum. 2012;64(9):2814–23.

5. Ward MM, Leigh JP. The relative importance of pain and functional disability to patients with rheumatoid arthritis. J Rheumatol. 1993;20(9):1494–9.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of the Key Predictors of Progression and Mortality of Rheumatoid Arthritis-Associated Interstitial Lung Disease;Diagnostics;2024-08-28

2. How to Distinguish Non-Inflammatory from Inflammatory Pain in RA?;Current Rheumatology Reports;2024-08-09

3. Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study;Lupus;2024-04-25

4. Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments;Journal of Clinical Medicine;2024-04-17

5. Health-Related Quality of Life Assessment in Sarcoidosis;Clinics in Chest Medicine;2024-03